Morningstar
•
Nov 04, 2026
Medline Inc.: Medline Earnings: Sales Continue to Outpace Expectations, but Bottom-Line Drag Persists
Summary
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Solstice Advanced Materials, Inc.
Nov 04, 2026
•
SOLS
SOLS: Lowering target price to $59.00
Nov 04, 2026
•
SOLS
KRMN: Raising target price to $38.00
Nov 04, 2026
•
KRMN
SOLS: What does Argus have to say about SOLS?
Oct 28, 2026
•
SOLS
KRMN: Raising target price to $36.00
Oct 28, 2026
•
KRMN
